US FDA approves phase 3 trial for new biological drug
Published: 2010-06-09 06:59:00
Updated: 2010-06-09 06:59:00
Apimeds Inc., a local biopharmaceutical company, said it has received approval from the U.S. Food and Drug Administration to conduct Phase III clinical trial of a drug for the treatment of autoimmune disease and pain relief in chronic arthritis.
Company officials said the approval comes after ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
